CLINICAL-EPIDEMIOLOGICAL AND MOLECULAR-GENETIC CHARACTERISTICS OF THE FIRST CASE OF ACUTE HEPATITIS E IN THE GRODNO REGION
Abstract
Background. The emergence of hepatitis E virus (HEV) in developed countries is driven by improved diagnostic tools, increased clinician awareness of the autochthonous nature of transmission and the potential for life-threatening acute and chronic liver damage. Objective. To present the first confirmed case of acute hepatitis E (AHE) caused by the E virus of the first genotype (HEV-1) in the Grodno region, registered in 2022. Material and methods. The patient is a native of Pakistan, who has been living and working in Grodno for recent years. He visited Italy and Pakistan several times within last six months, returned to Grodno 2 weeks before the onset of clinical manifestations of the disease. The patient was hospitalized in the Regional infectious diseases hospital. The methods for laboratory and etiological diagnosis of hepatitis included: general clinical methods, serological and molecular genetic ones (ELISA - IgM, IgG HEV; PCR - RNA HEV, genotyping and sequencing of the HEV genome). Results. Epidemiological, clinical and laboratory methods made it possible to exclude viral hepatitis A, B, C, D and establish the diagnosis of AHE of icteric (bilirubin at the height of the disease - 209.1 μmol/l, ALT - 1795 U/l), moderate form with a favorable outcome. IgM and IgG to HEV were detected in the patient's blood. HEV RNA was isolated from the patient's biological material. The isolated sequence in 100% bootstrap replications was assigned to HEV genotype 1. The insignificant value of the evolutionary distance between the "Grodno" sequence and the sequence isolated from a patient's body in Pakistan indicated a high degree of their homology, which made it possible to conclude that this case of AHE was imported. Conclusions. For the first time in the Grodno region, there was registered an imported case of AHE acquired during travel to HEV hyperendemic territory. The identified sequence is 100% HEV-1 genotype and 94.3% homologous to the sequence obtained from a patient in Pakistan. Under favourable conditions, HEV-1, which has a significant epidemic potential, can cause the development of HEV outbreaks.
References
Syed SF, Zhao Q, Umer M, Alagawany M, Ujjan IA, Soomro F, Bangulzai N, Baloch AH, Abd El-Hack M, Zhou EM, Arain MA. Past, present and future of hepatitis E virus infection: Zoonotic perspectives. Microb Pathog. 2018;119:103-108. https://doi.org/10.1016/j.micpath.2018.03.051.
Forni D, Cagliani R, Clerici M, Sironi M. Origin and dispersal of Hepatitis E virus. Emerg Microbes Infect. 2018;7(1):11. https://doi.org/10.1038/s41426-017-0009-6.
Khuroo MS, Khuroo MS. Hepatitis E: an emerging global disease – from discovery towards control and cure. J Viral Hepat. 2016;23(2):68-79. https://doi.org/10.1111/jvh.12445.
Kubánková M, Němeček V, Chalupa P, Mihalčin M, Vašíčková P. Hepatitidis E virus. Epidemiol Mikrobiol Imunol. 2016;65(1):4-14.
Barreiro P. Chronic hepatitis E: knowing what to look for, so it can always be found. AIDS Rev. 2013;15(3):191.
Pischke S, Potthoff A, Hauröder B, Schlué J, Manns MP, Cornberg M, Wedemeyer H. Hepatitis E virus infection: a paradigm shift? Dtsch Med Wochenschr. 2010;135(22):1129-1133. https://doi.org/10.1055/s-0030-1255136. (German).
Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24(9);1484-1493. https://doi.org/10.1111/j.1440-1746.2009.05933.x.
Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988-997. https://doi.org/10.1002/hep.25505.
Li B, Wu H, Miao Z, Hu L, Zhou L, Lu Y. Codon Usage of Hepatitis E Viruses: A Comprehensive Analysis. Front Microbiol. 2022;21(13):938651. https://doi.org/10.3389/fmicb.2022.938651.
Aslan AT, Balaban HY. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroenterol. 2020;26(37):5543-5560. https://doi.org/10.3748/wjg.v26.i37.5543.
Treagus S, Wright C, Baker-Austin C, Longdon B, Lowther J. The Foodborne Transmission of Hepatitis E Virus to Humans. Food Environ Virol. 2021;13(2):127-145. https://doi.org/10.1007/s12560-021-09461-5.
Vina-Rodriguez A, Schlosser J, Becher D, Kaden V, Groschup MH, Eiden M. Hepatitis E virus genotype 3 diversity: phylogenetic analysis and presence of subtype 3b in wild boar in Europe. Viruses. 2015;7(5):2704-2726. https://doi.org/10.3390/v7052704.
Sridhar S, Teng JLL, Chiu TH, Lau SKP, Woo PCY. Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants. Int J Mol Sci. 2017;18(4):869. https://doi.org/10.3390/ijms18040869.
Lee GH, Tan BH, Teo EC, Lim SG, Dan YY, Wee A, Aw PP, Zhu Y, Hibberd ML, Tan CK, Purdy MA, Teo CG. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk. Gastroenterology. 2016;50(2):355-357.e3.
Spancerniene U, Grigas J, Buitkuviene J, Zymantiene J, Juozaitiene V, Stankeviciute M, Razukevicius D, Zienius D. Prevalence and phylogenetic analysis of hepatitis E virus in pigs, wild boars, roe deer, red deer and moose in Lithuania. Acta Vet Scand. 2019;61(1):9. https://doi.org/10.1186/s13028-019-0443-7.
Murphy EG, Williams NJ, Jennings D, Chantrey J, Verin R, Grierson S, McElhinney LM, Bennett M. First detection of Hepatitis E virus (Orthohepevirus C) in wild brown rats (Rattus norvegicus) from Great Britain. Zoonoses Public Health. 2019;66(6):686-694. https://doi.org/10.1111/zph.12581.
Sridhar S, Yip CCY, Wu S, Cai J, Zhang AJ, Leung KH, Chung TWH, Chan JFW, Chan WM, Teng JLL, Au-Yeung RKH, Cheng VCC, Chen H, Lau SKP, Woo PCY, Xia NS, Lo CM, Yuen KY. Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant. Emerg Infect Dis. 2018;24(12):2241-2250. https://doi.org/10.3201/eid2412.180937.
Andonov A, Robbins M, Borlang J, Cao J, Hatchette T, Stueck A, Deschambault Y, Murnaghan K, Varga J, Johnston L. Rat Hepatitis E Virus Linked to Severe Acute Hepatitis in an Immunocompetent Patient. J Infect Dis. 2019;220(6):951-955. https://doi.org/10.1093/infdis/jiz025.
Horvatits T, Schulze Zur Wiesch J, Lütgehetmann M, Lohse AW, Pischke S. The Clinical Perspective on Hepatitis E. Viruses. 2019;11(7):617. https://doi.org/10.3390/v11070617.
Malinnikova EJu. Kliniko-jepidemiologicheskaja harakteristika gepatita E v Rossijskoj Federacii [masters thesis]. Moskva; 2014. 48 р. (Russian).
Arabej AA, Marchuk SI, Zhavoronok SV, Davydov VV, Kjuregjan KK, Mihajlov MI. Adaptirovannyj metod polimeraznoj cepnoj reakcii dlja vyjavlenija virusa gepatita E u cheloveka i zhivotnyh [Adapted method of polymerase chain reaction for detecting hepatits E virus for people and animal]. Voennaja medicina [Мilitary medicine]. 2018;3:86-92. edn: XYKMFV. (Russian).
Kumar S, Stecher G, Li M, Knyaz C, Tamura K. Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018;35(6):1547-1549. https://doi.org/10.1093/molbev/msy096.
Smith DB, Izopet J, Nicot F, Simmonds P, Jameel S, Meng XJ, Norder H, Okamoto H, van der Poel WHM, Reuter G, Purdy MA. Update: proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A). J Gen Virol. 2020;101(7):692-698.
Hasegawa M, Kishino H, Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol. 1985;22(2):160-174. https://doi.org/10.1007/BF02101694.
Аutomated genotyping and interpretation [Internet]. Available from: http://hev.glue.cvr.ac.uk/#/analysisTool.
Davydov VV, Zhavoronok SV, Rogacheva TA, Novik TP, Alatorceva GI, Nesterenko LN, Sidorov AV, Luhverchik LN, Mihajlov MI, Zverev VV. Rasprostranjonnost’ antitel k virusu gepatita E u naselenija regionov Respubliki Belarus [Prevalence of antibodies to the hepatitis e virus in the population of the Republic of Belarus]. Zhurnal mikrobiologii, jepidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2022;99(2):160-171. https://doi.org/10.36233/0372-9311-236. https://www.elibrary.ru/wpzhlf. (Russian).
Davydov VV, Zhavoronok SV, Anis’ko LA, Gasich EL, Marchuk SI, Semizhon PA, Karlsen AA, Kjuregjan KK, Mihajlov MI, Alatorceva GI. Izuchenie riskov zavoza gepatita E v Respubliku Belarus. In: Rubnikovich SP, Hryshhanovich VJa, editors. BGMU v avangarde medicinskoj nauki i praktiki. Sbornik nauchnyh trudov. Minsk: BGMU; 2020. Pt. 10; p. 297-305. (Russian).
Davydov VV, Zhavoronok SV, Anis’ko LA, Gasich EL, Marchuk SI, Semizhon PA, Potemkin IV, Karlsen AA, Kjuregjan KK, Mihajlov MI, Alatorceva GI, Krasochko PA, Borisovec DS, Prokopenkova TM. Geneticheskij polimorfizm virusa gepatita E v Respublike Belarus [Genetic diversity of hepatitis e virus in the Republic of Belarus]. Klinicheskaja infektologija i parazitologija [Clinical Infectology and Parasitology]. 2020;9(3):297-305. https://doi.org/10.34883/PI.2020.9.3.029. https://www.elibrary.ru/oxyyyw. (Russian).
